Rabinowits, G., Homsi, J., Nikanjam, M., Gentry, R., Strasswimmer, J., Venna, S., Migden, M., Chandra, S., Ruiz, E., Zhang, H., McGinniss, J., Seluzhytsky, A. and Desai, J. 2020. Demographics, Prior Therapies, and Reasons for Cemiplimab Treatment: Prospective CemiplimAb-rwlc Survivorship and Epidemiology (C.A.S.E.) Study in Patients with Advanced Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s125. DOI:https://doi.org/10.25251/skin.4.supp.125.